New drug proves effective in treating cancer-related wasting disease
New Pfizer drug shows effectiveness in treating cancer-related wasting disease or cachexia.
Advanced non-small cell lung cancer patients gain survival boost with new combination therapy
CANCER DIGEST – Feb. 24, 2024 – Patients with non-small cell lung cancer who have not responded to standard therapy achieved better...
Immunotherapy before and after surgery improved lung cancer outcomes
CANCER DIGEST -- Oct. 27, 2023 -- Lung cancer patients who underwent immunotherapy before and after surgery had a 32 percent lower risk...
New drug boosts disease-free survival in NSCLC
May represent a treatment shift to earlier use of targeted therapy against EGFR cancer CANCER DIGEST – Feb. 11, 2023 – Non-small cell...
Drug for rare lung cancer receives FDA approval
CANCER DIGEST – Jan. 7, 2023 – The US FDA has approved a new treatment for a rare type of lung cancer following a clinical trial led by...
New immunotherapy approach promises to improve cancer outcomes
CANCER DIGEST – Nov. 19, 2022 – Researchers at Albert Einstein College of Medicine have identified an additional protein cancer cells use...
